Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
30.5 HKD | +0.83% | +10.11% | -18.56% |
04-26 | RemeGen Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-04 | Remegen Gets US FDA Fast Track Designation for Primary Sjögren's Syndrome Medication | MT |
Sales 2024 * | 1.69B 233M 1.83B 18.68B | Sales 2025 * | 2.49B 343M 2.69B 27.5B | Capitalization | 25.2B 3.48B 27.23B 279B |
---|---|---|---|---|---|
Net income 2024 * | -1.15B -158M -1.24B -12.69B | Net income 2025 * | -688M -94.95M -743M -7.6B | EV / Sales 2024 * | 15.5 x |
Net Debt 2024 * | 1.01B 139M 1.09B 11.13B | Net Debt 2025 * | 1.82B 251M 1.96B 20.07B | EV / Sales 2025 * | 10.9 x |
P/E ratio 2024 * |
-13.4
x | P/E ratio 2025 * |
-22.5
x | Employees | 3,615 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 55.32% |
1 day | +0.83% | ||
1 week | +10.11% | ||
Current month | +12.34% | ||
1 month | +17.31% | ||
3 months | +57.70% | ||
6 months | -18.88% | ||
Current year | -18.56% |
Managers | Title | Age | Since |
---|---|---|---|
Jian Min Fang
CEO | Chief Executive Officer | 62 | 03/07/08 |
Shao Jing Tong
DFI | Director of Finance/CFO | 53 | 27/09/23 |
Ruyi He
CTO | Chief Tech/Sci/R&D Officer | 63 | 10/05/20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Xian Jing Hao
BRD | Director/Board Member | 59 | 10/05/20 |
Yun Jin Chen
BRD | Director/Board Member | 39 | 04/05/22 |
Jian Min Fang
CEO | Chief Executive Officer | 62 | 03/07/08 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.27% | 4 M€ | -27.92% | ||
0.12% | 2 M€ | -14.14% | ||
0.00% | 7 M€ | +1.95% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 30.5 | +0.83% | 1,169,158 |
25/04/24 | 30.25 | +2.89% | 1,931,164 |
24/04/24 | 29.4 | -2.00% | 801,796 |
23/04/24 | 30 | +5.82% | 2,057,000 |
22/04/24 | 28.35 | +2.35% | 450,534 |
Delayed Quote Hong Kong S.E., April 26, 2024 at 09:08 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.56% | 3.48B | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- 9995 Stock